These results suggest that although elevated serum TARC levels are associated with the presence of SSc-ILD, TARC levels do not correlate with the severity of SSc-ILD, suggesting that TARC cannot be a predictor of fibrotic lesions. The gene discussed is CCL17; the disease is systemic sclerosis.